Review confirms early diagnosis tool

February, 2010

A comprehensive survey confirms the value of an early diagnostic tool, and provides strong evidence for the central importance of amyloid-beta protein plaques in the development of Alzheimer’s.

A survey of more than 100 studies involving PIB-PET, a diagnostic tool that involves injecting a radiotracer called Pittsburgh compound B into the brain via the bloodstream, and imaging the brain with positron emission tomography (PET), has confirmed its sensitivity in detecting amyloid-beta protein plaques. The tool is not yet commercially available. The study also provides strong evidence supporting the theory that accumulation of amyloid-beta protein plaques in the brain is central to the development of Alzheimer’s. The findings, that amyloid deposits appear to reach a plateau early in the disease course, may explain why Alzheimer's patients have not responded to promising experimental drugs that target amyloid. It may be that they are being administered too late.

http://www.eurekalert.org/pub_releases/2010-02/uoc--nsm020910.php

Reference:

[182] Rabinovici, G. D., & Jagust W. J.
(2009). Amyloid imaging in aging and dementia: Testing the amyloid hypothesis in vivo.
Behavioural Neurology. 21(1), 117 - 128.

seniors

alzheimers-diagnosis

Alzheimers

Related News

Rates of new dementia cases may be falling

As we all know, people are living longer and obesity is at appalling levels. For both these (completely separate!) reasons, we expect to see growing rates of dementia. A new analysis using data from the long-running Framingham Heart Study offers some hope to individuals, however.

Mentally challenging activities key to a healthy aging mind

A study involving 39 older adults has found that those randomly assigned to a “high-challenge” group showed improved cognitive performance and more efficient brain activity compared with those assigned to a low-challenge group, or a control group.

Some cognitive training helps less-educated older adults more

Data from 2,800 participants (aged 65+) in the Advanced Cognitive Training for Independent and Vital Elderly (ACTIVE) study has revealed that one type of cognitive training benefits less-educated people more than it does the more-educated.

Omega 3 levels affect whether B vitamins can slow brain's decline

A study involving 266 people with mild cognitive impairment (aged 70+) has found that B vitamins are more effective in slowing cognitive decline when people have higher omega 3 levels.

Some chronic viral infections could contribute to age-related cognitive decline

Growing research has implicated infections as a factor in age-related cognitive decline, but these have been cross-sectional (comparing different individuals, who will have a number of other, possibly confounding, attributes).

Mediterranean diet reduces brain shrinkage in old age

Another study adds to the growing evidence that a Mediterranean diet is good for the aging brain.

Alzheimer's disease consists of 3 distinct subtypes

A two-year study which involved metabolic testing of 50 people, suggests that Alzheimer's disease consists of three distinct subtypes, each one of which may need to be treated differently. The finding may help explain why it has been so hard to find effective treatments for the disease.

More evidence that stress increases risk of Alzheimer's

A study involving both mice and human cells adds to evidence that stress is a risk factor for Alzheimer's.

Stroke speeds age-related cognitive decline

Data from 23,572 Americans from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study has revealed that those who survived a stroke went on to have significantly faster rates of cognitive decline as they aged.

Low vitamin D speeds age-related cognitive decline

A study involving 382 older adults (average age 75) followed for around five years, has found that those who don’t get enough vitamin D may experience cognitive decline at a much faster rate than people who have adequate vitamin D.

Pages